Year: 2017

2.21.2017 Secondary Announcement

SUBSCRIBE TO THE IPO BOUTIQUE NEWSLETTER   IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: GMS, Inc. Symbol: GMS Price: Last Trade $28.92 Trade Date: 2/23 Shares: 6 million[…]

New Filings & Terms 2.17.17

NEW FILINGS Company: J. Jill, Inc. Symbol: JILL Price: TBD Description: J.Jill is a nationally recognized women’s apparel brand focused on a loyal, engaged and affluent customer in the attractive 40-65 age segment. Trade Date: TBD Shares: TBD Underwriter(s): BofA Merrill Lynch, Morgan Stanley, Jefferies Co Manager(s): Deutsche Bank Securities, RBC Capital Markets, UBS Investment[…]

02.15.2017 Secondary Announcement

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Martin Midstream Partners L.P. Symbol: MMLP Price: Last trade $18.85 Description: Re-offer range $18.00-$18.25 Trade Date: 2/16 Shares: 2.6 million Underwriter(s)RBC[…]

02.14.2017 Secondary Announcement

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Seacoast Banking Corporation Symbol: SBCF Price: Last trade $23.97 Description: No re-offer range available Trade Date: 2/15 Shares: 4.2 million Underwriter(s)Guggenheim[…]

02.13.2017 Secondary Announcement

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aldeyra Therapeutics Inc. Symbol: ALDX Price: Last trade $4.75 Description: Re-offer $4.50 Trade Date: 2/14 Shares: 2.2 million Underwriter(s)Stifel, Canaccord Genuity,[…]

New Filings — Week ending 2.10.17

NEW FILINGS Company: Azul S.A. Symbol: TBD Price: TBD Description: They are the largest airline in Brazil in terms of departures and cities served, with 784 daily departures serving 101 destinations, creating an unparalleled network of 203 non-stop routes as of December 31, 2016. Trade Date: TBD Shares: TBD Underwriter(s): Citigroup, Deutsche Bank Securities, Itau[…]

02.09.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: BioTime Symbol: BTX Price: Last trade $3.01 Description: Re-offer $2.70-$2.75 Trade Date: 2/10 Shares: 5.7 million Underwriter(s)Raymond James & Associates Rating=Subscription[…]

02.08.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Sierra Oncology Symbol: SRRA Price: Last trade $1.42 Description: Re-offer $1.35 Trade Date: 2/9 Shares: 18.5 million Underwriter(s)Jefferies Rating=Subscription Needed

Roadshow buyouts becoming a ‘thing’

Mauser Group B.V. was expected to go public on Thursday and raise roughly $265mm if its 12.6mm offering was priced at the mid-point of the $20-$22 range. Instead, the PE firm, Clayton, Dubilier & Rice (CD&E), decided to sell the supplier of industrial rigid packaging products and reconditioning services to Stone Canyon Industries for an all-cash transaction of[…]

02.07.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Coherus Biosciences Symbol: CHRS Price: Last trade $26.65 Description: Re-offer range $24.00-$25.00 Trade Date: 2/8 Shares: 4.7 million Underwriter(s)J.P. Morgan, Citigroup,[…]

2.06.2017 Secondary Announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Antero Midstream Partners LP Symbol: AM Price: Last trade $33.89 Description: Re-offer range $33.20-$33.55 Trade Date: 2/7 Shares: 5 million Underwriter(s)Barclays,[…]

A Snapshot…of Snap’s S-1 filing

Snap, Inc. made its grand S-1 entrance on Thursday (2/2) with an official filing with the SEC. Talking heads instantly dissected the 200+ page document–everything from its financials to its user growth averages and ending with a potential valuation question. If we had to describe the filing in one word…it would be “aggressive”.  There’s a lot to digest, breakdown and[…]

Snap, Hamilton Lane highlight new filings in IPO Pipeline

NEW FILINGS Company: Hamilton Lane Incorporated Symbol: HLNE Price: TBD Description: They are a global private markets investment solutions provider with approximately $40 billion of assets under management and approximately $274 billion of assets under advisement. Trade Date: TBD Shares: TB Underwriter(s): J.P. Morgan, Morgan Stanley Co Manager(s): Goldman Sachs & Co., Keefe Bruyette &[…]

IPO Pricings – Ramaco Resources, Kimbell Royalty, IC Power

SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter  Ramaco Resources (Nasdaq: METC) — ‘METC’ priced 6mm shares at the midpoint of the range, $13.50. Kimbell Royalty Partners (NYSE: KRP) — ‘KRP’ priced 5mm shares at $18.00 — or $1.00 below the range.  The initial range for this deal was $19-$21. IC Power Pte (NYSE: ICP) — According[…]

2.2.2017 Secondary announcement-p.m.

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Neos Therapeutics Symbol: NEOS Price: Last trade $5.80 Description: Re-offer $5.00 Trade Date: 2/3 Shares: 5 million Underwriter(s)Cowen & Co., BMO[…]

Scroll to top
error: Content is protected !!